Increasing the Yield in Targeted Next-Generation Sequencing by Implicating CNV Analysis, Non-Coding Exons and the Overall Variant Load: The Example of Retinal Dystrophies
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Retinitis pigmentosa (RP) and Leber congenital amaurosis (LCA) are major causes of blindness. They result from mutations in many genes which has long hampered comprehensive genetic analysis. Recently, targeted next-generation sequencing (NGS) has proven useful to overcome this limitation. To uncover "hidden mutations" such as copy number variations (CNVs) and mutations in non-coding regions, we extended the use of NGS data by quantitative readout for the exons of 55 RP and LCA genes in 126 patients, and by including non-coding 5' exons. We detected several causative CNVs which were key to the diagnosis in hitherto unsolved constellations, e.g. hemizygous point mutations in consanguineous families, and CNVs complemented apparently monoallelic recessive alleles. Mutations of non-coding exon 1 of EYS revealed its contribution to disease. In view of the high carrier frequency for retinal disease gene mutations in the general population, we considered the overall variant load in each patient to assess if a mutation was causative or reflected accidental carriership in patients with mutations in several genes or with single recessive alleles. For example, truncating mutations in RP1, a gene implicated in both recessive and dominant RP, were causative in biallelic constellations, unrelated to disease when heterozygous on a biallelic mutation background of another gene, or even non-pathogenic if close to the C-terminus. Patients with mutations in several loci were common, but without evidence for di- or oligogenic inheritance. Although the number of targeted genes was low compared to previous studies, the mutation detection rate was highest (70%) which likely results from completeness and depth of coverage, and quantitative data analysis. CNV analysis should routinely be applied in targeted NGS, and mutations in non-coding exons give reason to systematically include 5'-UTRs in disease gene or exome panels. Consideration of all variants is indispensable because even truncating mutations may be misleading.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
A method and server for predicting damaging missense mutations.
Adzhubei, I. A., Schmidt, S., Peshkin, L., Ramensky, V. E., Gerasimova, A., Bork, P., Kondrashov, A. S., & Sunyaev, S. R. (2010) · Nature Methods · doi:10.1038/nmeth0410-248 · Cited by 13,194 · cited 1×
“Pathogenicity of a rare non-synonymous single nucleotide variations (nSNVs) scores of which were not yet predicted in dbNSFP were assessed using five in silico prediction software tools: SIFT [48], Mutation Taster [49], PolyPhen-2 [50], AlignGVGD [51,52] and PMut [53].”
MethodMutationTaster evaluates disease-causing potential of sequence alterations
Schwarz, J. M., Rödelsperger, C., Schuelke, M., & Seelow, D. (2010) · Nature Methods · doi:10.1038/nmeth0810-575 · Cited by 2,975 · cited 1×
“Pathogenicity of a rare non-synonymous single nucleotide variations (nSNVs) scores of which were not yet predicted in dbNSFP were assessed using five in silico prediction software tools: SIFT [48], Mutation Taster [49], PolyPhen-2 [50], AlignGVGD [51,52] and PMut [53].”
MethodHartong, D. T., Berson, E. L., & Dryja, T. P. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69740-7 · Cited by 2,924
Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP++
Davydov, E. V., Goode, D. L., Sirota, M., Cooper, G. M., Sidow, A., & Batzoglou, S. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1001025 · Cited by 1,757 · cited 1×
“An nSNV was considered likely pathogenic when at least three of these algorithms predicted that the variant is probably damaging and when it was predicted as conserved with the conservation prediction algorithms PhyloP [54] and GERP++ [55].”
BackgroundBotstein, D., & Risch, N. (2003) · Nature Genetics · doi:10.1038/ng1090 · Cited by 1,503 · cited 1×
“Patients without Mutations – possible Explanations As discussed above, mutations in known retinal dystrophy genes may escape detection because of their localization – about 15% of disease-causing mutations localize outside coding exonic sequences [35].”
BackgroundNCBI Reference Sequences (RefSeq): current status, new features and genome annotation policy
Pruitt, K. D., Tatusova, T., Brown, G. R., & Maglott, D. R. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1079 · Cited by 1,149 · cited 1×
“The resulting sequence data were compared to the reference sequence of the RefSeq database [62].”
Method
Cited by
Carss, K. J., Arno, G., Erwood, M., Stephens, J., Sanchis-Juan, A., Hull, S., Megy, K., Grozeva, D., Dewhurst, E., Malka, S., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.12.003 · Cited by 463
Self-citationAthanasiou, D., Aguila, M., Bellingham, J., Li, W., McCulley, C., Reeves, P. J., & Cheetham, M. E. (2018) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2017.10.002 · Cited by 373
Xue, Y., Ankala, A., Wilcox, W. R., & Hegde, M. R. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.122 · Cited by 349
Consugar, M. B., Navarro-Gomez, D., Place, E. M., Bujakowska, K. M., Sousa, M. E., Fonseca-Kelly, Z. D., Taub, D. G., Janessian, M., Wang, D. Y., Au, E. D., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2014.172 · Cited by 245
“It is also possible that some subjects have mutations that cannot be readily detected by sequencing-based approaches, such as CNVs 25,40 .”
Aref-Eshghi, E., Bend, E. G., Colaiacovo, S., Caudle, M., Chakrabarti, R., Napier, M., Brick, L., Brady, L., Carere, D. A., Levy, M. A., et al. (2019) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2019.03.008 · Cited by 201
The Spectrum of PAX6 Mutations and Genotype-Phenotype Correlations in the Eye
Lima Cunha, D., Arno, G., Corton, M., & Moosajee, M. (2019) · Genes · doi:10.3390/genes10121050 · Cited by 192
Molecular findings from 537 individuals with inherited retinal disease
Ellingford, J. M., Barton, S., Bhaskar, S., O'Sullivan, J., Williams, S. G., Lamb, J. A., Panda, B., Sergouniotis, P. I., Gillespie, R. L., Daiger, S. P., et al. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2016-103837 · Cited by 160
Genes and Mutations Causing Autosomal Dominant Retinitis Pigmentosa
Daiger, S. P., Bowne, S. J., & Sullivan, L. S. (2015) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017129 · Cited by 158
“…are in use: targeted retinal-gene capture NGS (Simpson et al. 2011; Audo et al. 2012; Neveling et al. 2012; O’Sullivan et al. 2012; Chen et al. 2013; Eisenberger et al. 2013; Glockle et al. 2013; Wang et al. 2014), whole-exome NGS (Bowne et al. 2011a; Ozgul et al. 2011; Tucker et al. 2011; Zeitz…”
BackgroundSorsby Fundus Dystrophy: Novel Mutations, Novel Phenotypic Characteristics, and Treatment Outcomes
Gliem, M., Müller, P. L., Mangold, E., Holz, F. G., Bolz, H. J., Stöhr, H., Weber, B. H. F., & Charbel Issa, P. (2015) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.14-15733 · Cited by 67
Self-citation
Metadata
- Authors
- Eisenberger, T., Neuhaus, C., Khan, A. O., Decker, C., Preising, M. N., Friedburg, C., Bieg, A., Gliem, M., Issa, P. C., Holz, F. G., Baig, S. M., Hellenbroich, Y., Galvez, A., Platzer, K., Wollnik, B., Laddach, N., Ghaffari, S. R., Rafati, M., Botzenhart, E., Tinschert, S., Börger, D., Bohring, A., Schreml, J., Körtge-Jung, S., Schell-Apacik, C., Bakur, K., Al-Aama, J. Y., Neuhann, T., Herkenrath, P., Nürnberg, G., Nürnberg, P., Davis, J. S., Gal, A., Bergmann, C., Lorenz, B., & Bolz, H. J.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-11-12
- Volume
- 8
- Issue
- 11
- Pages
- e78496
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2063347806
- Cited by
- 228
- References
- 7
- FWCI
- 9.14
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.